Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy.
about
Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical StudiesAltered B cell signalling in autoimmunity.Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors.Disruption of Splenic Lymphoid Tissue and Plasmacytosis in Canine Visceral Leishmaniasis: Changes in Homing and Survival of Plasma Cells.Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study.Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis.Pre-symptomatic autoimmunity in rheumatoid arthritis: when does the disease start?Upregulation of FcγRIIB by resveratrol via NF-κB activation reduces B-cell numbers and ameliorates lupus.The origin of the plasma-cell heterogeneity.Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus.
P2860
Q28067334-29F2E348-BE8C-4463-85B0-E1F98F45E3F7Q33924642-CB4AD66F-F1F7-419B-892C-34E43BA5BB67Q35544326-5E36D1F4-10C5-439D-A19B-6478FF6D70B2Q36034698-C873419E-2494-424D-B433-E6A1DF80D84DQ36975931-585B4978-4C1A-4EAE-AC36-E5B6110E1472Q38259495-9A1A3549-1196-4EAF-BDE1-5679769D2CC5Q38880624-2BF5E607-D8B5-4592-ACD2-90FDC88C1ED9Q42370436-8F549CCA-5657-4642-A69D-49641E8F4B34Q43116935-5EB4312C-5348-4291-82E1-B372BBB4055DQ55266542-E1C68D65-CB30-4DE0-BDB3-F8DC2852B952
P2860
Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy.
@ast
Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy.
@en
type
label
Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy.
@ast
Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy.
@en
prefLabel
Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy.
@ast
Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy.
@en
P2093
P2860
P356
P1476
Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy.
@en
P2093
Claude-Agnès Reynaud
Jean-Claude Weill
Marc Michel
Matthieu Mahévas
P2860
P356
10.3389/FIMMU.2013.00494
P577
2013-12-27T00:00:00Z